Company Information

CIN
Status
Date of Incorporation
27 September 1945
State / ROC
Mumbai / ROC Mumbai
Last Balance Sheet
31 March 2023
Last Annual Meeting
30 September 2023
Paid Up Capital
50,000,000
Authorised Capital
50,000,000

Directors

Sanjeev Khandelwal
Sanjeev Khandelwal
Director
over 2 years ago
Vijay Kumar Goel
Vijay Kumar Goel
Director/Designated Partner
over 2 years ago
Mahesh Prasad Mehrotra
Mahesh Prasad Mehrotra
Director
about 18 years ago

Past Directors

Anuradha Sanjeev Khandelwal
Anuradha Sanjeev Khandelwal
Additional Director
about 9 years ago
Sunita Khandelwal
Sunita Khandelwal
Additional Director
about 9 years ago
Subhash Kashinath Pai Kakode
Subhash Kashinath Pai Kakode
Additional Director
almost 15 years ago
R V S Mani Mani
R V S Mani Mani
Director
over 22 years ago

Patents

A Method Of Manufacturing Pharmaceutical Extented Release Tablets

N/A

Pharmaceutical Preparations Comprising Cefixime Trihydrate

N/A

Pharmaceutical Preparations Containg Alendronate Sodium

An oral composition in tablet form containing therapeutic amounts of alendronate sodium for release of the alendronate sodium in the stomach and by passing the oesophagus, comprising a compacted granulated core with the alendronate sodium embedded in an inert fiber matrix, lined with a moisture barrier film and encl...

Registered Trademarks

Myciclib Khandelwal Laboratories

[Class : 5] Medicinal And Pharmaceutical Preparations And Substances.

Lenvaliz Khandelwal Laboratories

[Class : 5] Pharmaceutical And Medical Preparation; Medicinal Preparations For Use In Oncology; Pharmaceutical Preparations And Substances For Use In Oncology; Anti Cancer Preparations; Pharmaceutical Preparations, Substances And Compositions For The Treatment And Prevention Of Cancer; Biopharmaceuticals For The Treatment Of Cancer.

Lapaliz Khandelwal Laboratories

[Class : 5] Pharmaceutical And Medical Preparation; Medicinal Preparations For Use In Oncology; Pharmaceutical Preparations And Substances For Use In Oncology; Anti Cancer Preparations; Pharmaceutical Preparations, Substances And Compositions For The Treatment And Prevention Of Cancer; Biopharmaceuticals For The Treatment Of Cancer.
View +262 more Brands for Khandelwal Laboratories Private Limited.

Charges

43 Crore
30 January 2015
Axis Bank Limited
5 Crore
19 April 2011
Punjab National Bank
1 Crore
23 February 2011
Punjab National Bank
1 Crore
30 November 2007
Punjab National Bank
11 Crore
16 May 2007
Punjab National Bank
3 Crore
12 September 2006
Punjab National Bank
2 Crore
12 April 2005
Punjab National Bank
10 Crore
28 June 2004
Punjab National Bank
10 Crore
12 April 2005
Others
0
16 May 2007
Punjab National Bank
0
30 November 2007
Others
0
28 June 2004
Others
0
19 April 2011
Punjab National Bank
0
30 January 2015
Axis Bank Limited
0
12 September 2006
Punjab National Bank
0
23 February 2011
Punjab National Bank
0
12 April 2005
Others
0
16 May 2007
Punjab National Bank
0
30 November 2007
Others
0
28 June 2004
Others
0
19 April 2011
Punjab National Bank
0
30 January 2015
Axis Bank Limited
0
12 September 2006
Punjab National Bank
0
23 February 2011
Punjab National Bank
0

Documents

Form Addendum to AOC-4 CSR-18032024
Form MGT-7-27122023_signed
Optional Attachment-(1)-09112023
Copy of MGT-8-09112023
List of share holders, debenture holders;-09112023
Form MGT-7-09112023
Form MSME FORM I-30102023
Form AOC-4(XBRL)-07112023_signed
XBRL document in respect Consolidated financial statement-28102023
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-28102023
Form MSME FORM I-11092023_signed
Form MSME FORM I-10092023_signed
Form MSME FORM I-29042023_signed
Form Addendum to AOC-4 CSR-19012023_signed
Form MGT-7-28112022
Optional Attachment-(3)-28112022
Optional Attachment-(2)-28112022
Optional Attachment-(1)-28112022
Copy of MGT-8-28112022
List of share holders, debenture holders;-28112022
XBRL document in respect Consolidated financial statement-08112022
Optional Attachment-(2)-08112022
Optional Attachment-(3)-08112022
Optional Attachment-(1)-08112022
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-08112022
Form AOC-4(XBRL)-08112022
Form MSME FORM I-01112022
Form MSME FORM I-01112022_signed
Form MSME FORM I-01112022
Form DPT-3-23062022_signed